Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
Top Cited Papers
Open Access
- 15 March 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 92 (6) , 464-474
- https://doi.org/10.1093/jnci/92.6.464
Abstract
BACKGROUND: Human papillomavirus (HPV) is the main cause of cervical neoplasia. Because few population-based studies have investigated the prevalence of type-specific infection in relation to cervical disease, we studied a high-risk population, estimating the prevalence of HPV infection and the risk associated with various HPV types. METHODS: We screened 9175 women in Guanacaste, Costa Rica, to obtain a referent standard final diagnosis, and tested 3024 women for more than 40 types of HPV with a polymerase chain reaction-based system. RESULTS: Among women with normal cytology, HPV infections peaked first in women younger than 25 years, and they peaked again at age 55 years or older with predominantly non-cancer-associated types of HPV and uncharacterized HPV types. Low-grade squamous intraepithelial lesions (LSILs) (n = 189) decreased consistently with age. The prevalence of high-grade squamous intraepithelial lesions (HSILs) (n = 128) peaked first around age 30 years and again at age 65 years or older. Seventy-three percent of LSILs were HPV positive, with HPV16 being the predominant type (16% of positive subjects). HPV was found in 89% of HSILs and 88% of cancers, with HPV16 being strongly predominant (51% and 53% of positive subjects). Virtually all HSILs and cancers had cancer-associated HPV types, with high odds ratios (ORs) and attributable fractions around 80%. Risk for HPV16 was particularly high (OR for HSILs = 320, 95% confidence interval [CI] = 97-1000; OR for cancer = 710, 95% CI = 110-4500). CONCLUSIONS: We confirm the early decline of HPV infection with age but note increased prevalence after menopause, which could be related to a second peak of HSILs, an observation that warrants further investigation. At least 80% of HPVs involved in cervical carcinogenesis in this population have been characterized. Polyvalent vaccines including the main cancer-associated HPV types may be able to prevent most cases of cervical disease in this region.Keywords
This publication has 40 references indexed in Scilit:
- PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systemsJournal of Clinical Microbiology, 1997
- Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste ProjectRevista Panamericana de Salud Pública, 1997
- Epidemiology of Genital Human Papillomavirus InfectionThe American Journal of Medicine, 1997
- Declining Prevalence of Cervicovaginal Human Papillomavirus Infection With Age Is Independent of Other Risk FactorsSexually Transmitted Diseases, 1996
- Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical DysplasiaJNCI Journal of the National Cancer Institute, 1995
- Analysis of Short Novel Human Papillomavirus SequencesBiochemical and Biophysical Research Communications, 1994
- Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal WomenThe Journal of Infectious Diseases, 1994
- Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age‐dependentInternational Journal of Cancer, 1993
- The Bethesda System for Reporting Cervical/Vaginal Cytologic DiagnosesThe American Journal of Surgical Pathology, 1992
- The 1988 Bethesda System for Reporting Cervical/Vaginal Cytological DiagnosesJAMA, 1989